Rights and permissions
About this article
Cite this article
CHOP + ibritumomab tiuxetan beneficial in DLBCL in elderly. Inpharma Wkly. 1629, 7 (2008). https://doi.org/10.2165/00128413-200816290-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816290-00023